3930-20-9
ChemmineR-0127140935XD

 18 18  0  0  0  0            999 V2000
    4.9292   -5.8600    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.8509   -5.8560    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.6375   -0.9049    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 S   0  0
   -4.9395    1.3433    0.0000 O   0  0
   -3.8969   -0.4545    0.0000 O   0  0
   -4.9371    0.1435    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 11 17  1  0
 17 18  2  0
 18  8  1  0
M  END
> <canonical_smiles>
CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1

> <CAS_NO>
3930-20-9

> <Source>
CCRIS

> <Activity>
0

> <WDI_Name>
SOTALOL;SOTALOHCL

> <REFERENCE>
OKINE,LKN, IOANNIDES,C AND PARKE,DV, STUDIES ON THE POSSIBLEMUTAGENICITY OF BETA-ADRENERGIC BLOCKER DRUGS, TOXICOL. LETT. 16(3-4):167-174,1983

> <MC_Example>
1

> <MC_Pred>
0

> <DEREK_Example>
0

> <DEREK_Pred>
0

> <Set>
TRAIN

> <Molecular_Weight>
272.3638 __  __ 

$$$$
